Testing new chemoradiation regimens for head-and-neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 1, 2005, Pages 5-6

  Eisbruch, Avraham ^a,b   Normolle, Daniel P ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MITOMYCIN C;

CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; EDITORIAL; HEAD AND NECK CARCINOMA; HUMAN; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; RELAPSE;

ANTIBIOTICS, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; MITOMYCIN; PORFIROMYCIN; RANDOMIZED CONTROLLED TRIALS;

EID: 11144289622     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.09.029     Document Type: Editorial

References (10)

1. A.A. Forastiere, H. Goepfert, M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098
2. J.P. Pignon, J. Bourhis, C. Domenge, L. Designe Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer Lancet 355 2000 949 955
3. J.S. Cooper, T.F. Pajak, A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
4. E.E. Vokes, M.S. Kies, D.J. Haraf Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer J Clin Oncol 18 2000 1652 1661
5. A. Eisbruch, D.S. Shewach, C.R. Bradford Gemcitabine concurrent with irradiation for locally advanced head and neck cancer: A phase I trial and intracellular drug incorporation study J Clin Oncol 19 2001 792 799
6. W. Van den Bogaert, E. van der Schueren, J.C. Horiot The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: Long-term results and side effects Radiother Oncol 35 1995 91 99
7. M. Henke, R. Laszig, C. Rube Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial Lancet 362 2003 1255 1260
8. P. Warde, B. O'Sullivan, J. Aslanidis A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer Int J Radiat Oncol Biol Phys 54 2002 9 13
9. Haffty BG, Wilson LD, Son YH, et al. Concurrent chemo-radiotherapy with mitomycin-C compared with porfiromycin in squamous cell cancer of the head and neck: Final results of a randomized clinical trial. Int J Radiat Oncol Biol Phys 2005;61:121-130.
10. D.M. Brizel, M.E. Albers, S.R. Fisher Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798 1804